22nd Annual Wharton Health Care Business Conference

Speakers and Panels: Panels

Payer-Provider Convergence
From Volume to Value: New Frontiers in Payer / Provider Collaboration

9:25 AM – 10:35 AM (Grant Room)


As payers and providers tackle the shift from volume to value, established players are collaborating on new reimbursement and care delivery models – while new entrants are emerging to enable the market’s transformation. With this panel, we’ll hear from leaders on the new economic frontiers. What are the bounds of competition and collaboration? What’s the right approach: vertical integration or diffused ecosystem plays? And how does one stay ahead in the current dual-reimbursement model environment?

Panelists:

Nick Bluhm - Director of Strategy, Remedy Partners
Nick Bluhm

Nick Bluhm

Director of Strategy
Remedy Partners

Nick Bluhm is Director of Strategy & Government Policy at Remedy, a venture-backed technology company that helps realign the healthcare system to encourage collaboration around episodes of care. As part of Remedy’s participation in the Bundled Payments for Care Improvement Initiative, he helps providers understand how to use clinical and financial integration to improve their performance in the Initiative.

Prior to Remedy, Nick served at the Center for Medicare & Medicaid Innovation, helping to design the Comprehensive ESRD Care Initiative, a demonstration model focused on providing care across the continuum for patients afflicted with End-Stage Renal Disease. Before that, he counseled the Centers for Medicare & Medicaid Services as an Attorney in the Office of General Counsel.

Nick received a J.D. from the University of Virginia and B.S./M.A. degrees from the George Washington University.

Niyum Gandhi - Executive Vice President and Chief Population Health Officer, Mount Sinai Health System
Niyum Gandhi

Niyum Gandhi

Executive Vice President and Chief Population Health Officer
Mount Sinai Health System

Niyum Gandhi is the Executive Vice President and Chief Population Health Officer of the Mount Sinai Health System. In this role, he oversees Mount Sinai’s transition from a primarily fee-for-service model of care to one that is also inclusive of value and risk-based population health.

Mr. Gandhi leads Mount Sinai Health Partners and helps align the Health System’s clinical and economic transformations in support of Mount Sinai’s vision to be the leading population health manager in the competitive New York market, as well as the best possible partner to the Health System’s broad physician community. This includes fostering care management and clinical model redesign to ensure that high-value care is delivered by the Health System and its partners, and working with payers to establish the new economic models that support the delivery of value-based care.

Prior to his position at Mount Sinai, Mr. Gandhi served as a Partner in the Health and Life Sciences consulting practice of Oliver Wyman in Chicago, where he focused on value-based health care strategy and transformation for physician groups, hospitals, and health plans. At Oliver Wyman, Mr. Gandhi also worked with a variety of Accountable Care Organizations (ACOs) and other population health management companies, helping them design and implement value-based clinical models, develop value-based contracts and integrated product distribution strategies, align physician incentives toward value, and establish the appropriate infrastructure to support population health management.

Mr. Gandhi holds an A.B. in economics and finance from Harvard University. He has authored several articles on ACOs, payer/provider partnerships, and physician engagement, and served as a conference speaker on a variety of issues related to population health and value-based care.

Lynn Garbee - Senior Director, Value Based Reimbursement and Collaborative Care, Cigna Healthcare
Lynn Garbee

Lynn Garbee

Senior Director, Value Based Reimbursement and Collaborative Care
Cigna Healthcare

Lynn Garbee is Senior Director, Value Based Reimbursement and Collaborative Care, for Cigna Healthcare. In her role, she is responsible for balancing the execution of strategic reimbursement across both fee-for-service and fee-for-value. She and her team develop the playbook of contracting strategies utilized across the enterprise, ranging from P4P programs, ACOs, episodes of care and capitation.

Before joining Cigna, Ms. Garbee led the Solution Design team for McKesson Health Solutions, helping payer clients in addressing claims payment challenges and preparing for value-based reimbursement. Previously she led the claims consulting team and used analytic techniques to enable payers to optimize usage of their McKesson Health Solutions products, predominantly in claims editing and fraud solutions.

Previously, Ms. Garbee directed claims operations for several entrepreneurial healthcare ventures focused on value-based reimbursement, and headed the payment policy team and the contract management area of a major health plan. She spent several years in actuarial and benefits consulting and also managed health and welfare benefits of a Fortune 500 company. Ms. Garbee holds a Bachelor of Arts degree from Brown University and a Master of Business Administration in healthcare management and operations from the Wharton School of Business.

Chris Garcia - Vice Chairman and Chief Financial Officer, Remedy Partners
Chris Garcia

Chris Garcia

Vice Chairman and Chief Financial Officer
Remedy Partners

Mr. Garcia is a founding member of the Remedy team, Vice Chairman and Chief Financial Officer, and leads the forward progress of Remedy Partners.

Before joining Remedy, Chris spent ten years in Healthcare private equity as both an Operating Partner and Managing Partner leading investments in hospital supply chain management, non-emergency transport services, specialty pharmacy distribution, pain management services, outpatient rehabilitation providers, behavior health services, Medicaid eligibility and business process outsourcing services.

Prior to his private equity career, Chris spent 10 years founding and growing an episode management company focused on managing healthcare for work-related injuries on behalf of property and casualty insurers and private employers. His company, National Healthcare Resources, developed a specialty preferred provider network, developed a telephonic case management business unit to manage episodes and grew to $170 million in annual revenue before being sold to its largest competitor.

Mr. Garcia began his professional career as a Certified Public Accountant before spending 7 years with Solomon Brothers and Greenwich Capital in the mortgage sales and trading business. He is a graduate of The University of Florida and resides in Fairfield, CT with his wife and two children.

Vivek Garipalli - Co-Founder and CEO, Clover Health
Vivek Garipalli

Vivek Garipalli

Co-Founder and CEO
Clover Health

Vivek Garipalli is the co-founder and CEO of Clover Health, a health insurance company leveraging data to proactively improve health outcomes, filling gaps in care and reducing avoidable costs. Prior to founding Clover, Vivek founded CarePoint Health, a fully integrated healthcare system in New Jersey. Through his role at CarePoint – whose mission is to serve uninsured and underinsured patient populations – Vivek experienced the misalignment of providers and insurance companies first-hand.

Prior to CarePoint, Vivek owned and operated various outpatient facilities. He began his career in finance, holding roles at Credit Suisse First Boston, J.P. Morgan Partners and Blackstone Group.

Vivek is active in health tech, serving as a board member of Flatiron Health and Doctor Evidence. He earned an undergraduate degree in business administration at Emory University with a concentration in entrepreneurship.

Dr. Griffin Myers - Founder, Oak Street Health
Dr. Griffin Myers

Dr. Griffin Myers

Founder
Oak Street Health

Dr. Griffin Myers is a board certified emergency physician, entrepreneur, and nationally recognized thought leader in healthcare innovation and value-based care. He began his career as a global strategy consultant at The Boston Consulting Group working primarily at the intersection of healthcare and financial services in markets around the globe including Brazil, China, and Western Europe. In 2012 he founded Oak Street Health, a Chicago-based primary care organization serving over 12,000 patients in 15 locations across the Midwest. Oak Street is a value-based, at-risk model focused on providing high-quality, coordinated care to low-income older adults. Oak Street's model has generated over 40% reductions in hospitalizations, strong evidence-based preventive care metrics, and net promoter scores over 90%. Dr. Myers has a B.S. from Davidson College, an M.D. with Alpha Omega Alpha honors from University of Chicago Pritzker School of Medicine, and an M.B.A. from the University of Chicago Booth School of Business. He completed his residency in emergency medicine at Harvard Medical School's Massachusetts General and Brigham & Women’s Hospitals. He is a diplomate of the American Board of Emergency Medicine and an Adjunct Instructor of Emergency Medicine at Northwestern University Feinberg School of Medicine.

Terry Stone - Managing Partner, Health & Life Sciences, Oliver Wyman (Moderator)
Terry Stone

Terry Stone

Managing Partner, Health & Life Sciences
Oliver Wyman
(Moderator)

Terry Stone is the global Managing Partner of Oliver Wyman’s Health & Life Sciences practice group. She specializes in the development of differentiated growth strategies for health payer, provider, pharmaceutical, and biotech clients, as well as health enablement companies. She has led initiatives focused on improving the cost and quality of healthcare services, establishing innovative partnerships across players in the healthcare sector, developing ACOs and other value-based solutions, and redesigning organizations to support their strategic transformations. Prior to joining the Health & Life Sciences practice, Terry was a partner in Oliver Wyman’s Financial Services practice. She has worked at Dell Computer, in the publishing industry, and at a small business-to-business software start-up. She earned a BA in chemistry from the College of the Holy Cross and an MBA from the Kenan-Flagler Business School at the University of North Carolina.


Biotech, Pharma & Devices
Big vs. Small: The Race to Create the Next Blockbuster Therapeutics

9:25 AM – 10:35 AM • Meade Room


In this new age of medical innovation, small biotechs are increasingly stealing the headlines with major drug and business model innovations – forcing “Big Pharma” to respond with M&A deals, partnership strategies, and new approaches to pricing and R&D. In this panel, key leaders from Big Pharma, small & medium sized new biotech, and traditional biotech will debate what it takes to win in the current competitive environment, how their organizations are adapting to change, and who stands to prevail in the race to create the next blockbuster therapeutics.

Panelists:

Anastasia G. Daifotis, MD - Chief Scientific Officer, Janssen North America
Anastasia G. Daifotis, MD

Anastasia G. Daifotis, MD

Chief Scientific Officer
Janssen North America

Anastasia G. Daifotis, M.D., is the Chief Scientific Officer, Janssen North America. Anastasia leads the Janssen Scientific Affairs Organization and the Janssen Medical and Scientific Affairs Council.

As the leader of Janssen Scientific Affairs, Anastasia sets the medical strategy for Janssen North America and plays a key role in shaping our overall business strategy. She is responsible for accelerating the development of medical and scientific capabilities essential to differentiating in a value-based healthcare system, such as Real World Evidence and healthcare economics, and for pharmacovigilance and for Medical Information, including our Call Center operations.  She partners closely with our R&D and Global Medical Affairs leadership on product development programs and plays an important medical role in licensing and acquisitions.  As leader of the Medical and Scientific Affairs Council for Janssen North America, Anastasia is responsible for shaping the medical and scientific vision for the region internally and representing Janssen externally on advisory and policy-making bodies across the region.

Anastasia brings extensive scientific, medical and commercial leadership experience, spanning drug development, medical affairs, and marketing.  She was formerly with Karos Pharmaceuticals, Inc., a privately held biopharmaceutical company, where as President and Chief Executive Officer she led development efforts in pulmonary hypertension and other orphan diseases, worked with internal scientists to develop and implement company research and development strategy, oversaw operations and represented the company with investors, scientific experts and pharmaceutical industry partners.  Prior to joining Karos, Anastasia was Senior Vice President of Clinical Development at MacroGenics, Inc., where she oversaw clinical development of several novel oncologic, infectious disease and autoimmune therapies.

Before joining MacroGenics, Anastasia had a distinguished 16-year career at Merck, where she held medical affairs, commercial and R&D leadership roles, including Vice President and General Manager, Global Human Health, Respiratory, Bone, Arthritis and Analgesia Franchise and Vice President, Clinical Research Therapeutic Area, Head, Bone, Endocrine, Immunology and Analgesia. In her last position, Vice President, Global Medical Affairs, she led the organization that provided medical support and information to Merck franchises, markets, healthcare professionals and patients regarding company products and related disease areas.

Anastasia graduated from Princeton University with an undergraduate degree in Biology and received her M.D. from Albany Medical College. She held clinical and research fellowships in Endocrinology and a Howard Hughes fellowship at the Yale University School of Medicine and Yale-New Haven Hospital.

Sophie Kornowski-Bonnet, PhD - Global Head, Roche Partnering, Roche
Sophie Kornowski-Bonnet, PhD

Sophie Kornowski-Bonnet, PhD

Global Head, Roche Partnering
Roche

Sophie Kornowski-Bonnet, Ph.D., is Global Head of Roche Partnering and a member of the Roche Corporate Executive Committee, based at Roche’s headquarters in Basel, Switzerland.

Her career has taken her from Paris to New York, via Chicago. She began at Abbott Diagnostics in France, first in regulatory affairs. From there, she moved to Abbott Pharmaceuticals in Chicago and was in market research, then a medical representative in New York. For four years in the United States and then two years in France, she held positions in strategic marketing and as business unit head of neuroscience for Sanofi Winthrop.

She further pursued her professional career within the Merck-Sharp & Dohme Group as head of strategic planning, France, before relocating to Israel as general manager to create and develop the affiliate for the group, subsequently holding respectively the functions of vice-president of rheumatology and analgesia in the U.S., then rheumatology and cardiology head for France.

She joined Roche France in March 2007 as general manager, and was then appointed head of Roche Partnering in February 2012. She holds a Ph.D. in pharmacy from the Faculty of Pharmacy in Paris, France, and an MBA in marketing and finance from the University of Chicago. She also has the distinction of having been inducted into the French Legion of Honor (Ordre national de la Légion d'honneur) by the French Minister of Research in recognition of her achievements. In her personal time, Sophie enjoys jogging, art, being with family and friends – and more than anything else, spending time with her teenage son.

Dr. Maria Maccecchini - President and CEO, QR Pharma
Dr. Maria Maccecchini

Dr. Maria Maccecchini

President and CEO
QR Pharma

Maria Maccecchini received her PhD in biochemistry from Rockefeller University and spent two years at Caltech as a postdoc in molecular biology. She took her first job at Mallickrodt as research scientist and her second job as general manager of Bachem Bioscience, a US subsidiary of a Swiss company.

In the early 1990s she started her own biotech company—Symphony Pharmaceuticals. After acquiring a Scottish and a Japanese company, Symphony later changed its name to Annovis. The company develops, manufactures, and markets a variety of nucleic acid-based products and services for businesses in the life sciences sector. In 2001, Annovis was acquired by Transgenomic Inc.

After the sale of her company Dr. Maccecchini joined two angel group funds – Robin Hood Ventures and Mid-Atlantic Angel Group. She mainly invests in the life science sector; biotechnology, diagnostics and medical devices. She serves on several boards of biotechnology companies, organizations that promote entrepreneurship, international trade, women, charitable organizations as well as the Board of Robin Hood Ventures. Dr. Maccecchini does not only invest dollars in early-stage companies, but also mentors them in start up, strategy, management and finance.

In late 2008 Dr. Maccecchini started her second company, QR Pharma, with technology licensed from the NIH and Torrey Pines. The company is developing two drugs for the treatment of neurodegenerative disorders, like Alzheimer’s disease and Parkinson’s disease: one targets early stage AD and PD and may stop the progression of the diseases, whereas the second one targets late stage AD and may stabilize the decline. Posiphen, the lead compound successfully completed 3 phase I study demonstrating that it is safe, enters the brain, and normalizes brain levels of toxic proteins back to the levels seen in healthy normal volunteers. Posiphen totally recovered memory and learning in Alzheimer’s mice, restored normal gut motility and movement patterns in Parkinson’s mice and is entering a phase II SILK study in Alzheimer patients.

Jeffrey D. Marrazzo - Co-Founder and CEO, Spark Therapeutics, Inc.
Jeffrey D. Marrazzo

Jeffrey D. Marrazzo

Co-Founder and CEO
Spark Therapeutics, Inc.

Jeffrey D. Marrazzo is co-founder and CEO of Spark Therapeutics, Inc. (NASDAQ: ONCE), a gene therapy leader developing one-time, life-altering treatments to transform the lives of patients with debilitating diseases. Under Jeff's leadership, Spark has raised more than $365 million, established a global collaboration with Pfizer in hemophilia B, and advanced its lead program for rare, blinding conditions through a successful Phase 3 clinical trial. Previously, Jeff built and sold the first genetic testing benefit management and pharmacogenomics medicines company to CVS Caremark. A former advisor to Pennsylvania Governor Edward G. Rendell, Jeff received his B.A. in economics and B.S.E. in systems science and engineering from the University of Pennsylvania, and holds a dual M.B.A. / M.P.A. from The Wharton School and Harvard University.

Erik Pupo - Managing Director, North America Clinical and Health Management Services, Accenture (Moderator)
Erik Pupo

Erik Pupo

Managing Director, North America Clinical and Health Management Services
Accenture
(Moderator)

Erik Pupo serves as a Managing Director in the Accenture Health Client Service Group, where he manages a team of over 200 professionals within the Clinical and Health Management Services tea. His role spans North America and includes clients representing the provider, payer and life sciences industries. He currently works across 11 different clients, including Experian Health, Baycare Health System, Baptist Health, and Cigna. He has worked for over 18 years in healthcare, including senior positions in federal, state, and commercial healthcare programs and initiatives, and has served in a large number of senior leadership roles within the healthcare industry, including senior roles within HIMSS, AHIMA, WEDI and AMIA.


Healthcare Finance
Picking Winners in a Fast-Changing Market: Investing in Healthcare Innovation

10:45 AM – 11:55 AM (Grant Room)


In the face of drastic changes, incumbents are consolidating and new entrants are emerging to disrupt legacy healthcare models, thanks to a potent mix of new regulations, new technologies and fast-evolving consumer demand. For investors, this means navigating a complicated landscape to identify the sectors and models ripe for disruption. In this panel, leaders from across the continuum of healthcare investing will debate what it takes for a startup to disrupt an incumbent, and for an incumbent to disrupt itself.

Panelists:

Ateet Adhikari - Vice President, Healthbox
Ateet Adhikari

Ateet Adhikari

Vice President
Healthbox

Ateet Adhikari has led Healthbox’s investment group since 2012 with $13m under management from 25 LPs. He has invested in 85 companies through this fund and also supports a new, single-LP fund ($35m) that made it’s first investment earlier this year. Prior to Healthbox, his professional experience includes early-stage financing, M&A and VC advisory work for McDermott Will & Emery and Roberts McGivney Zagotta, serving a range of clients. Ateet also has private and public healthcare advisory experience, working with the Clinton Health Access Initiative and Huron Consulting Group. His first investment role came in 2009 when he helped structure, develop an investment strategy and begin deployment of a $20 microfund investing in Central and South America.  Ateet received a Bachelor of Arts in Economics from Northwestern University, his Juris Doctorate from the University of Illinois College of Law and his Masters of Public Administration from the Harvard Kennedy School of Government.

Anna Haghgooie - Managing Director, Sandbox Industries
Anna Haghgooie

Anna Haghgooie

Managing Director
Sandbox Industries

Anna Haghgooie is a managing director of Sandbox Industries, a Chicago-based venture capital firm focused on connecting established corporations with disruptive startups. Anna focuses on investing in healthcare innovation through the BlueCross BlueShield Venture Funds. She currently serves on the board of directors of ZeOmega, Contessa, Axial Healthcare, Allay, and Everymove. Previously she served on the board of directors of naviHealth and Change Healthcare and was a board observer of Essence Group Healthcare. Previously Anna held roles as the general manager at an integrative healthcare start-up, covered the healthcare markets as an associate director of corporate finance at Fitch Ratings and she started her career in the Financial Management Program at GE Capital. Anna earned a bachelor’s degree from the University of Michigan and a MBA with honors from the University Of Chicago Booth School Of Business. Anna is a Fellow of the inaugural class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network. She lives in Chicago, IL with her husband and two children.

Adele Oliva - Co-Founder and Partner, 1315 Capital
Adele Oliva

Adele Oliva

Co-Founder and Partner, 1315 Capital

Adele Oliva brings over 25 years of finance and healthcare experience to 1315 Capital, including 18 years in private equity. Throughout her investing career, she has focused on commercial stage specialty pharmaceutical, medical technology and healthcare service investments.

Ms. Oliva co-founded 1315 Capital in 2014 to establish a firm focused on healthcare growth investing. She was recruited to Quaker Partners, which she joined in 2007, to expand their growth and expansion stage investing practice. Prior to Quaker, Ms. Oliva was Co-Head of US Healthcare at Apax Partners, a global private equity firm, where she started in 1997.

Forbes has recognized Ms. Oliva on its Midas List of top 100 technology investors worldwide, top 10 life science investors and top women in venture capital.

Ms. Oliva has served on the board of many high growth companies including Ascent Healthcare Solutions (acquired by Stryker), EKR Therapeutics (acquired by Cornerstone Therapeutics), ESP Pharma (acquired by Protein Design Labs), Esprit Pharma (acquired by Allergan), Precision Dermatology (acquired by Valeant), Prometheus Labs (acquired by Nestle) and SkinMedica (acquired by Allergan). She currently serves on the boards of Novasom, Onkos Surgical, TearScience and TelaBio.

Prior to entering private equity as a Kauffman Fellow in 1997, Ms. Oliva built a strong foundation in finance and healthcare at CoreStates in commercial banking and Baxter Healthcare in marketing and business development. Ms. Oliva received a BSc from St. Joseph's University and a MBA from Cornell University, where she was awarded the Albert Fried Fellowship.

David Pegg - Partner, EEF
David Pegg

David Pegg

Partner
EEF

Mr. Pegg is a Partner at EEF. Prior to EEF, Mr. Pegg spent ten years at MVP Capital Partners. While at MVP, Mr. Pegg focused on lower-middle market buyouts and growth equity investments in healthcare, insurance services, building products and rotorcraft services. Before joining MVP, Mr. Pegg was an Analyst for J.P. Morgan Chase Private Bank. Mr. Pegg serves on the Board of Directors of MedTest and Prospira PainCare. Mr. Pegg holds a B.A. from Yale University and an M.B.A. from Villanova University School of Business.

Trevor Price - Founder and Managing Partner, Oxeon Partners
Trevor Price

Trevor Price

Founder and Managing Partner
Oxeon Partners

Over the course of a 20-year career, Trevor has started, built, shut down, funded, bought and sold technology and service companies, largely in the healthcare industry as an entrepreneur, investor and executive search consultant. Currently, Trevor serves as the Chairman of Oxeon Holdings, a healthcare growth services firm that connects our healthcare company partners with the fundamental drivers of business growth: great people, transformational business development partnerships, strategic investments, next generation business ideas and other growth-related services.

On a day-to-day basis, Trevor leads Oxeon Partners, an Invested Executive Search firm that finds the right leaders to drive growth for healthcare technology and service companies. Trevor also serves as the Managing General Partner of Oxeon Investments I LLC and Oxeon Investments II LLC, which provide strategic growth capital to venture-capital and private equity-backed healthcare technology and service companies. He also is a Founder and on the Board of Directors and Investment Committee of Cien Ventures, a venture studio that leverages Oxeon Partners’ network of relationships to conceive and start healthcare technology and service companies.

Ray Falci - Managing Director, Cain Brothers (Moderator)
Ray Falci

Ray Falci

Managing Director
Cain Brothers
(Moderator)

Ray Falci leads Cain Brothers’ HCIT and Revenue Cycle Management practices and also focuses on the healthcare distribution, specialty pharmacy and PBM sectors. Mr. Falci joined Cain Brothers in 2006 and has advised on a wide range of merger, buyside advisory, and recapitalization transactions, including sales to strategic acquirers and private equity firms. Mr. Falci’s notable transactions include advisory services to Blue Cross Blue Shield of Tennessee and The Regence Group on the take-private of the Trizetto group, the sale of the FutureScripts PBM to Catalyst Health Solutions, and the sale of the Outsource Group to Parallon/HCA. He is a member of the Firm’s Executive Committee.

Prior to joining Cain Brothers, Mr. Falci was an equity research analyst for nine years, primarily at Bear Stearns, where he was named to Institutional Investor’s All Star Team for five consecutive years.

Mr. Falci graduated from The Cooper Union with a Bachelor’s of Engineering in Mechanical Engineering. He earned a Master’s Degree from Columbia University in Mechanical Engineering and an MBA from the Wharton School of the University of Pennsylvania.


Empowered Healthcare Consumer
Winning Hearts and Wallets: Helping Consumers Navigate Healthcare

10:45 AM – 11:55 AM • Meade Room


When it comes to navigating healthcare, consumers today face a complicated task: from selecting a plan, to finding care, staying healthy, and more. Incumbents are certainly evolving to adapt; but just as quickly, new entrants are flooding the market with the goal of becoming consumers’ trusted healthcare advisors. And yet, questions remain about to what extent consumers even want to manage their own care! This panel will feature leaders from across the continuum of consumer healthcare organizations. What does the future hold for consumer-focused models? What will it take to compete, collaborate and win?

Panelists:

Linda Bernier - Vice President, Market Solutions, Welltok
Linda Bernier

Linda Bernier

Vice President, Market Solutions, Welltok

Linda Bernier is the Vice President of Market Solutions for Welltok where she is responsible for driving each market segment in a highly scalable way to meet unique population health management goals. She brings over 20 years of senior leadership expertise in healthcare and HIT organizations leading marketing, strategy, product management, business development and consulting teams.

Linda was most recently the Senior Vice President of Enterprise Strategy and Communications for TriZetto, a Cognizant Company. Prior to TriZetto, she was the General Manager for Oracle (Siebel) Healthcare and was responsible for building the company’s healthcare vertical. She also held roles as the Vice President of Strategic Development for Premera Blue Cross, and as a top-level manager for Deloitte Consulting in their healthcare practice.

She is currently a board member for The Moxie Exchange and a former board member for the Healthcare Care Executives Group (formerly MCEG).

Linda holds a BA from Wellesley College, graduating Magna Cum Laude and an MBA with a concentration healthcare from Wharton Class of 1993.

Brian Dolan - Chief Strategy and Partner Integration Officer, Rally Health
Brian Dolan

Brian Dolan

Chief Strategy and Partner Integration Officer
Rally Health

Brian is a seasoned health care innovator with more than 25 years of health care and consulting experience. Over this time, he has gained a comprehensive and balanced understanding of today’s health care system from the perspective of all the primary stakeholders (consumers, providers, employers and insurers).

Prior to Rally Health, Brian was chief customer solutions officer for ActiveHealth Management. Earlier in his career, he was senior vice president of business development for Uniprise, a UnitedHealth Group business serving large employers, and held leadership roles at Towers Perrin, where he was principal and Northeast sales and marketing leader. Brian earned an MBA from Clark University and a BA from Bowdoin College.

Veer Gidwaney - Chief Executive Officer and Co-Founder, Maxwell Health
Veer Gidwaney

Veer Gidwaney

Chief Executive Officer and Co-Founder
Maxwell Health

Veer Gidwaney is Chief Executive Officer and Co-Founder at Maxwell Health and a proven entrepreneur and innovator whose energy and intelligence have long been devoted to solving the problems of our time alongside his brother and co-founder Vinay.

Prior to co-founding Maxwell, Veer and Vinay co-founded DailyFeats, a popular mobile app that motivates and rewards members to improve their health and well-being. Veer was also the Director and Co-Founder of Humanity Calls, a fundraising tournament website designed to bring together non-profits, companies and individuals focused on addressing global causes. In 2010, Humanity Calls, in partnership with eBay, ran a successful tournament for the environment that resulted in donations to dozens of top non-profits.

In the midst of completing his degree in business at the University of Western Ontario, Veer also co- founded and served as CEO of Control-F1, an industry leader in support automation,which raised more than $13 million in venture capital and was acquired in December of 2005 CA Technologies. Veer went on to serve as head of sales for one of CA Technologies' North American business units with more than $75 million in annual revenue, and later served as Executive Advisor to the EVP of Technology and Products.

Sally Poblete - CEO, Wellthie
Sally Poblete

Sally Poblete

Founder and CEO
Wellthie

Sally has been a leader and innovator in the health care industry for 20 years. She founded Wellthie in 2013 out of a deep passion for making health insurance more simple and approachable for consumers. She had a successful career leading product development at Anthem, one of the nation’s largest health insurance companies. An entrepreneur at heart, she also ran a long-term health care business and worked at several health care start-ups like HealthMarket and Medscape. Sally received her B.S. in Management, magna cum laude from New York University and received her MBA from Wharton School at the University of Pennsylvania, specializing in Health Care Management.

Tom Spann - Founder, Vice Chair, and Chief Operating Officer, Accolade
Tom Spann

Tom Spann

Founder, Vice Chair, and Chief Operating Officer
Accolade

Since co-founding Accolade in 2007, Tom Spann has held many roles, most recently serving as CEO. “I’ve been furniture mover, printer repairman, recruiter, salesperson, reporting analyst, caterer and instigator,” he says. Through it all, Tom has led Accolade's growth on a simple principle: give people the help and information they need, and they’ll make the right choices.

In assuming the role of COO, Tom’s focus is making sure Accolade’s current clients and customers are getting thee value and service they deserve. In this capacity, he also plays a key role in determining the future of Accolade’s core product – our health assistance services and the technology that supports them and our customers.

Tom is motivated by making a “meaningful and positive difference” in the nation’s healthcare system and the lives of American families. He previously served as senior managing partner at Accenture, where he led the North America Products Group, a $2 billion, 10,000-employee operating unit. During his 26-year career at Accenture, Tom specialized in shaping and leading large-scale change programs including several pharmaceutical industry start-ups, most notably Astra-Merck.

Tom holds a bachelor’s degree in economics from the Wharton School of the University of Pennsylvania.

He and his wife, Nancy, have two daughters: Jenny and Meredith.

Renya Spak, MPH - Partner, Mercer Health and Benefits (Moderator)
Renya Spak, MPH

Renya Spak, MPH

Partner
Mercer Health and Benefits
(Moderator)

Renya is a Partner in the Mercer Health and Benefits New York City office and leads Mercer’s “Intellectual Capital Accelerator”, a function within the newly created North America Health Innovation Team. In this capacity, Renya is responsible for the cultivation and timely delivery of new integrated perspectives, solutions, and strategic offerings across the health care spectrum that seek to deliver unprecedented value to our clients.

Renya previously served as the Total Health Management Practice Leader for the Midwest where she focused on creating population health strategies for jumbo multinational employers. She led projects such as the design and delivery of custom care management solutions, development of new advocacy models, and the creation of compelling engagement plans that achieved industry-leading health outcomes – and perhaps more importantly – supported broader workforce goals like optimizing retention and productivity. This work spanned many industries including pharma, manufacturing, technology, and academia.

Renya graduated from Rutgers College with a Bachelor of Science in Public Health and completed her Master’s of Public Health degree at the University of Michigan School of Public Health.


Disruptive Care Delivery
Putting Patients at the Center: The Race to Re-engineer How Care is Delivered

2:15 PM – 3:25 PM (Grant Room)


New reimbursement models are yielding new models of care – but it’s not yet clear which are best positioned to succeed at-scale. Will it be primary care centered ACOs? Major health systems’ population health schemes? Or a host of new services entirely: retail clinics, telehealth offerings, or on-demand home care? Most importantly: What do these new models mean for patients in terms of quality, access and cost? Featuring leaders from innovative incumbent organizations, as well as new entrants to the care delivery space, this panel will tackle what the future holds in terms of care settings, technology tools, and patient engagement tactics – and what it means for patients and physicians alike.

Panelists:

Michelle Donald, MD - Medical Director, Value Based Care, Northwell Health
Michelle Donald, MD

Michelle Donald, MD

Medical Director, Value Based Care
Northwell Health

Michelle Donald, MD, MPH is a physician practicing in Pediatrics and Preventive Medicine; she currently serves as the Medical Director of Value Based Care for Northwell Health. In this role she works on a number of pay for performance programs aimed at improving the health and wellness of Medicaid and Medicare patients. She also leads efforts to integrate care managers, dedicated to the care of complex patients, into outpatient practices.

Dr. Donald is a graduate of Temple University Medical School. She trained in Pediatrics at North Shore-LIJ and completed a Preventive Medicine residency at Stony Brook Medical School. She has a Master’s in Public Health from the Mailman School at Columbia University. Dr. Donald is also an assistant professor of Pediatrics at Hofstra University Medical School.

Dr. Donald has extensive skill in navigating managed care, CMS and JACHO regulations. Principal strengths are in the areas of clinical technology system implementations, strategic thinking, team building and developing educational and communication initiatives.

Nancy J. Gagliano, MD - CMO, CVS/minuteclinic; Senior Vice President, CVS Health
Nancy J. Gagliano, MD

Nancy J. Gagliano, MD

CMO, CVS/minuteclinic
Senior Vice President, CVS Health

Nancy J. Gagliano, M.D., MBA is Chief Medical Officer of CVS/minuteclinic and Senior Vice President of CVS Health. CVS/minuteclinic is the largest and fastest growing retail medical clinic provider in the United States. A member of the CVS/minuteclinic leadership team since 2010, Dr. Gagliano is responsible for physician oversight, clinical quality, expansion of services, strategic alliances with Health Systems as well as functions as the Medical Executive to CVS digital activities. CVS/minuteclinic nurse practitioners and physician assistants have seen more than 27 million patients to date and have received a 95 percent patient satisfaction rating.

Prior to joining the company, Dr. Gagliano spent more than 21 years at Massachusetts General Hospital. Most recently, she served as the Senior Vice President of Practice Improvement at Massachusetts General Hospital where she oversaw ambulatory quality, service, operations improvement and integration of technology for MGH’s 400 ambulatory practices.

Dr. Gagliano is a graduate of Union College and Harvard Medical School. She completed her internship and residency in internal medicine at the Brigham and Women’s Hospital. In 1989, she completed a fellowship in Adolescent Medicine at The Children’s Hospital in Boston. She is a board- certified internist and practiced as a primary care provider at MGH’s Women’s Health Associates. In 2001, Dr. Gagliano was named by Boston Magazine as one of Boston’s “Top Docs” for women.

In addition, while working at MGH, Dr. Gagliano was an Assistant Professor of Medicine at Harvard Medical School. In this role she was an educator of medical students, residents, fellows and faculty. Her research and teaching efforts focused on developing physician leaders and also the integration of technology into the practice environment.

Brian Mathis - Senior Vice President of Strategy and Payment Innovation, Surgical Care Affiliates
Brian Mathis

Brian Mathis

Senior Vice President of Strategy and Payment Innovation
Surgical Care Affiliates

Brian serves as SCA’s Senior Vice President of Strategy and Payment Innovation. Prior to SCA, Brian served as a Manager at Blue Ridge Partners (a boutique revenue growth strategy consulting firm) and as an Assistant Analyst in the Macroeconomics Division of the Congressional Budget Office. Brian is on the board of the Ambulatory Surgery Center Association. He earned a Bachelor of Arts from Emory University, where he was a Phi Beta Kappa honoree, and an MBA from the Darden Graduate School of Business Administration at the University of Virginia .

Andrew Schutzbank, MD - VP, Clinical Development, Iora Health
Andrew Schutzbank, MD

Andrew Schutzbank, MD

VP, Clinical Development
Iora Health

Andrew’s passion for revolutionizing health care began as a medical student at Tulane in pre- and post-Katrina New Orleans, continuing during his Internal Medicine & Primary Care residency at the Beth Israel Deaconess Medical Center. Andrew has worked across Iora Health since its founding: building the collaborative care platform, advancing a dynamic model of primary care including direct patient care, new market development and practice operations. In addition to his roles across Iora Health, Andrew is on the teaching faculty at Harvard Medical School affiliated Beth Israel Deaconess Medical Center, writes professionally and at the Schutzblog.com and is a founding member of Primary Care Progress. He, his wife Whitney and son Max are avid skiers and travelers and recently welcomed their daughter Madalyn Rose into the world this past Thanksgiving.

Amit Shah - Market Leader and VP Operations, Paladina Health
Amit Shah

Amit Shah

Market Leader and VP Operations
Paladina Health

Amit currently serves as market leader for Paladina Health’s Mountain Market. He partners with client groups to provide great patient experiences and improved health outcomes at a lower cost. Amit is part of a passionate team of caregivers and operators that are delivering patient centric, evidence based care. Amit joined Paladina Health in 2012 and has served in both the client services and clinical operations group.

Prior to joining Paladina Health, Amit was a founding member of DURON Energy, a start up focused on providing reliable, affordable energy to people living at the bottom of the pyramid. From 2008 to 2010, Amit was Vice President of Operations for DURON - responsible for end-to-end operations as well as market delivery strategy and execution. Before starting DURON, Amit was a management consultant with McKinsey & Company working on manufacturing operations, supply chain management and business strategy. While at McKinsey, he worked on a variety of projects including biotechnology manufacturing and generic pharmaceutical supply chain strategy. Prior to McKinsey, Amit worked for Steelcase, Inc. and Johnson & Johnson where he focused on Lean manufacturing and supply chain.

Amit received his MBA from the Stanford Graduate School of Business and his BS and MS in Industrial and Operations Engineering from the University of Michigan.

Amit works on the alumni board for Engineering Global Leadership Program, likes to fly airplanes, practice martial arts and be outside.

Igor Belokrinitsky - Partner, Strategy& (Moderator)
Igor Belokrinitsky

Igor Belokrinitsky

Partner
Strategy&
(Moderator)

Igor Belokrinitsky is a Partner in the healthcare practice of Strategy&, the strategy arm of PwC. Igor works with the executives and boards of mission-driven hospitals, health systems and health plans to develop innovative, value-based strategies and care models. In the course of ten years, he has helped over thirty clients grow, differentiate, diversify, and achieve greater “system-ness” – by using a collaborative, consumer-centric, data-driven and physician-led transformation approach. His work includes helping to design and build some of the first healthcare bundles, retail clinics, and private insurance exchanges in the nation.

Igor is a co-author of the firm’s perspectives on provider, payor and pharmacy strategy. He has written extensively on population health, bundles, and access improvement. He holds an MBA (with honors) from the Ross School of Business at the University of Michigan and a BBA in Finance (summa cum laude) from the Price School of Business at the University of Oklahoma.


Clinical Data Analytics
Getting Personal: Harnessing Analytics for New Patient Insights

2:15 PM – 3:25 PM (Meade Room)


With the sheer amount of data now held in electronic health records and the shift to value based payment models, the ability to transform clinical data into meaningful insights has never been more vital. This has touched off a race between large and small organizations alike, as they compete and collaborate to draw new insights from a deluge of sources – patient records, genomic sequencing, social media, biometric trackers and more. Featuring leaders from some of the most exciting incumbent and early-stage companies in the space, this panel will explore how players are separating signal from noise to deliver new models of care.

Panelists:

Joanne Burns - Senior Vice President and Chief Strategy Officer, Cerner
Joanne Burns

Joanne Burns

Senior Vice President and Chief Strategy Officer
Cerner

Joanne Burns, senior vice president and chief strategy officer, works directly with the CEO to advance the company's strategic initiatives and directions.

Burns partners closely with clients to drive value creation through action plans that spark technology and industry advances inside their organizations.

Previously, Burns was chief information officer and executive director of the Tiger Institute for Health Innovation, a joint venture between Cerner and the University of Missouri Health System. In the Tiger Institute, she created the model for how Cerner clients leverage technology as a strategic enabler to achieve their mission and realize their vision.

Through her work with the electronic medical record, including computerized physician order entry, Burns led the organization from a HIMSS Analytics EMR Adoption Model Level 3 to a Level 7 in less than 3 years. Under her leadership, University of Missouri Health Care has received the Health Informatics Most Wired Award in 2011 & 2012, was named a US News & World Report’s Most Connected Hospital, and received the 2011 Missouri Quality Award.

In addition, the Tiger Institute collaborated with the University of Missouri School of Medicine on the award of a $13.3M CMS Healthcare Innovation Challenge grant – Leveraging Information Technology to Guide High Tech, High Touch Care (LIGHT2).

Prior to her role at the Tiger Institute, Burns was vice president, Global and Specialty Solution Strategy, Navigator Organization. For six years, she served as the Intellectual Property (IP) lead for the academic and pediatric communities, international clients, and was responsible for the development of PowerChart Oncology™, PowerChart Maternity® and FetaLink®.

Before joining Cerner in 2004, Burns held various positions in health care spanning 22 years, including clinical and IT leadership roles at Memorial Sloan-Kettering Cancer Center in New York City, and Stanford University Medical Center and Lucile Packard Children’s Hospital in Palo Alto, California. She has published articles in peer-reviewed journals, and spoken in national forums on a variety of topics related to oncology care, critical care and the use of information technology in health care.

Joanne received a bachelor of science in nursing degree from the State University of New York at Plattsburgh. She also has a master’s degree in health services administration.

Marie Dunn - Director, Analytics, Health Catalyst
Marie Dunn

Marie Dunn

Director, Analytics
Health Catalyst

Marie Dunn is Director, Analytics at Health Catalyst, a data warehousing, analytics, and outcomes improvement company. During her tenure, she has served in leadership roles on the company’s accountable care product line and in developing the firm’s professional services strategy. Previously, Marie served as a Senior Consultant at The Advisory Board Company, helping to launch and lead the firm’s meaningful use consulting service. Marie has also worked with Partners HealthCare, InterSystems, and SMART Platforms in health IT strategy roles. Marie holds a MS in Health Policy and Management from Harvard School of Public Health, and a BA in Comparative Literature and Economics from The University of Virginia.

Josh Gray - Vice President, Research, athenahealth
Josh Gray

Josh Gray

Vice President, Research
athenahealth

Josh Gray is Vice President of Research at athenahealth. Josh oversees data analytics across a national network of 75,000+ providers who use athenahealth services. His team’s mission is to understand and report on activity from across the health care system. Focus areas include reimbursement patterns, provider activity, disease surveillance, as well as broad legislative impact. His team works in partnership with leading academic researchers, public health agencies, and foundations, including the Robert Wood Johnson Foundation, with which it has partnered to track the impact of the Affordable Care Act.  Prior to joining athenahealth, Josh occupied senior research positions at the Advisory Board Company, a health care consultancy in Washington, DC, and worked as a consultant at the Boston Consulting Group.  He has an MBA in Finance and Health Care Services from the Wharton School of Business and an AB in History from Brown University.

Sunanda Saxena - Associate Partner, IBM Global Business Services
Sunanda Saxena

Sunanda Saxena

Associate Partner
IBM Global Business Services

Sunanda Saxena is a management consultant with 15+ years’ of experience advising clients on business transformation, growth strategy, marketing strategy and operations improvement.

At IBM, she advises life sciences client executives on engagements ranging from business transformation, portfolio prioritization to business process improvement. She specializes in digital and analytics enabled healthcare transformation, helping client C-suite bring outcomes driven, patient centric healthcare solutions and services to market.

Prior to IBM, Sunanda managed consumer insights for Marico Limited, a US$700 million Indian consumer products company. She led marketing analytics and research for Marico’s portfolio of 14 brands spanning personal care, grooming, and wellness categories in emerging markets.

At ACNielsen, Sunanda managed multiple Fortune 500 client accounts, led multi-country marketing strategy consulting teams, advising clients on marketing strategy ranging from product innovation and new product development, pricing, advertising effectiveness assessment to sales volume forecasting.

She has an M.B.A. from The Wharton School with a dual major in Finance and Strategic Management, a Graduate Diploma in Communications majoring in Marketing Research and an Undergraduate degree in Statistics (honors).

Bob Watson - President, NantHealth
Bob Watson

Bob Watson

President
NantHealth

Bob has over 30 years of experience in the healthcare information technology industry as a CEO, board member and advisor to multiple companies.

Bob was named President of NantHealth, LLC in January 2015. Previously, he served as Streamline Health’s President and CEO from 2011 until 2015. He continues as a member of the Streamline Health’s Board of Directors, which he joined in 2011. Prior to Streamline, he was President and Chief Executive Officer and a director of DocuSys, Inc., a leading provider of anesthesia information systems that was acquired by Merge Healthcare Inc. in March 2010.

Prior to joining DocuSys, he was Executive Vice President of Business Development of Concuity, a healthcare division of Trintech, Plc. Before that position, he was President and Chief Executive Officer and a director at Concuity, Inc., which was acquired by Trintech, Plc. in December 2006.

Prior to joining Concuity in 2001, Bob had been a senior executive at several healthcare organizations throughout his career including Cerner Corporation, American Medical Response (now Envision Health) and AlternaCare Corp., Additionally, he was an independent director of Satori Labs, Inc. from 2009 until it’s sale to Quality Systems, Inc. in 2011.

Bob holds undergraduate degrees from Syracuse University in Information and Library Science and Health Policy Studies and a Master of Business Administration with a concentration in Hospital Administration and Finance from the Wharton School of Business at the University of Pennsylvania.

Steve Kelly - Director, McKinsey & Company (Moderator)
Steve Kelly

Steve Kelly

Director
McKinsey & Company
(Moderator)

Steve Kelly is a Director with McKinsey & Company. He is the former head of McKinsey’s Philadelphia Office, and he currently leads McKinsey’s Healthcare Technology Practice. In his 18+ years at McKinsey, Mr. Kelly has served a range of clients including health insurance payors, P&C and life insurance carriers, and other financial services firms. He has also served a range of public sector clients, focusing on healthcare, finance and technology. Steve’s client service covers a broad range of business topics including: strategy, growth, distribution, service operations, performance management, organization design, sourcing, underwriting, claims, and change management. He has also served clients on a broad range of technology topics including: IT strategy, IT performance transformation, managing large IT mega-projects, technology organization and governance, technology innovation, Lean IT, technology enabled operations, and IT shared services. Steve also serves on the Board of Trustees for the Franklin Institute Steve received his JD from Harvard Law School and completed his undergraduate degree in Economics at the University of Virginia. Steve currently resides in Villanova, PA with his wife Michelle and their two sons.

Wharton HCC Website

Be sure to visit the new Wharton Healthcare Club Website for the latest information on the Wharton healthcare community including upcoming events and industry speaker series lectures.

Visit HCC Website

WHCBC@Social

Connect with other conference attendees, speakers, and panelists ahead of the conference, and follow the latest updates.

Pulse Magazine

The Pulse - 2016 Edition

The Pulse is an annual publication which is distributed to all attendees of this Conference.

Download

The Wharton Health Care Conference is not just the best conference organized by students but one of the most impressive gatherings of industry leaders tackling timely and important issues in the health care industry.

Stelios Papadopoulos, Ph.D., Chairman and Founder, Exelixis

Sponsors


Bronze Sponsors

AmerisourceBergen Cigna Kindred Healthcare Regeneron

Sponsors

BDO Change Healthcare Genentech Johnson & Johnson Eli Lilly Lumeris Medtronic MTS Health Partners Oliver Wyman Penn Biotech Group Welltok